Gelteq Ltd. GELS

What this company does

We are a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. Our principal products are edible gels, which we refer to as gels, and their application in gel-based dosage forms. Our current product suite consists of multiple products that sit within five core verticals — for pets, sports, pharmaceutical (pharma), over-the-counter (OTC) and nutraceutical — all of which leverage our patent pending multiple-ingredient dosage forms, and that we expect to have a wide range of applications and consumers. We currently focus our efforts on out-licensing our technology to companies to develop and create new products they can manufacture and sell within their established and researched markets, while we continue to manufacture our existing products under license (“white label”). We designed our gel platform to enhance the tolerability and stability of drugs while maintaining their efficacy.

Written from the business description in Gelteq Limited's annual report to the U.S. Securities and Exchange Commission, filed 17 November 2025. Every sentence was checked against that document before publication.